Baidu
map

精神心理科

订阅

MedSci主页 / 所有栏目 / 精神心理科

失眠症治疗迎来曙光：FDA已批准卫材的Dayvigo

2019-12-24 Allan MedSci原创

FDA失眠症Dayvigo
关注

卫材公司近日宣布，FDA已经批准Dayvigo（lemborexant）用于治疗以睡眠发作和/或睡眠维持困难为特征的成人失眠症。该公司指出，Dayvigo（lemborexant）将于2020年4月上旬上市。

卫材公司近日宣布，FDA已经批准Dayvigo（lemborexant）用于治疗以睡眠发作和/或睡眠维持困难为特征的成人失眠症。该公司指出，Dayvigo（lemborexant）将于2020年4月上旬上市。

据卫材公司称，Dayvigo的获批是基于对大约2000名成年失眠症患者进行的关键性III期SUNRISE 1和SUNRISE 2试验。在试验中，与安慰剂相比，Dayvigo在主观和客观评估方面均显示出在睡眠发作和睡眠维持方面的显著优势。该公司指出，在两项研究中，该药物均与停药后的反弹性失眠无关，也没有停药后戒断反应。


原始出处：

http://www.firstwordpharma.com/node/1689489#axzz68z4pBXnX

本文系梅斯医学（MedSci）原创编译整理，转载需授权!


版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1081914, encodeId=28ec10819141d, content=国内什么时候上市, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecc72219008, createdName=13320f3bd5m, createdTime=Sun Dec 19 22:09:39 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643060, encodeId=3f99164306010, content=<a href='/topic/show?id=0c3d5e2871' target=_blank style='color:#2F92EE;'>#Dayvigo#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5728, encryptionId=0c3d5e2871, topicName=Dayvigo)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1e223091112, createdName=bshuang, createdTime=Sat Aug 01 20:43:00 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725183, encodeId=cb2e1e251836a, content=<a href='/topic/show?id=58476021257' target=_blank style='color:#2F92EE;'>#曙光#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60212, encryptionId=58476021257, topicName=曙光)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=180c33737541, createdName=yangpeizhi, createdTime=Mon Jun 01 12:43:00 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377482, encodeId=22893e7482b2, content=好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/12/3ce6763501d2a73b61c6ba263da91b0a.jpg, createdBy=b41a2669073, createdName=280218318, createdTime=Fri Dec 27 10:41:55 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377455, encodeId=00a13e7455ee, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201031/68bd1e468a5b4b94a6d4d57ed4253bc5/e6bf210dcac542b890ccc1ae1e433a21.jpg, createdBy=2eb51948381, createdName=1e109f88m97(暂无匿称), createdTime=Thu Dec 26 17:11:13 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377436, encodeId=f86e3e7436b5, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/03/0e492dda8bcc1f98474b74c2863aca87.jpg, createdBy=068d2446376, createdName=Dr Z, createdTime=Thu Dec 26 06:22:57 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1299388, encodeId=9c481299388ce, content=<a href='/topic/show?id=59d64429252' target=_blank style='color:#2F92EE;'>#失眠症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44292, encryptionId=59d64429252, topicName=失眠症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a4d285, createdName=日月, createdTime=Thu Dec 26 00:43:00 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447948, encodeId=975a144e9482c, content=<a href='/topic/show?id=72233658193' target=_blank style='color:#2F92EE;'>#卫材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36581, encryptionId=72233658193, topicName=卫材)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de215370353, createdName=yyanpro@23cn.c, createdTime=Thu Dec 26 00:43:00 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377408, encodeId=66993e740891, content=好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xjZ9qh3bhXrJtUlmycKGfQKPuADVZQsdNAQj5IrHHlzbGsDwScictBgogYRk8KhicpgEKwTEfOHgqw/0, createdBy=bc931611963, createdName=jin321, createdTime=Wed Dec 25 12:49:50 CST 2019, time=2019-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377390, encodeId=be0d3e739092, content=好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Wed Dec 25 05:14:27 CST 2019, time=2019-12-25, status=1, ipAttribution=)]
    2021-12-19 13320f3bd5m

    国内什么时候上市

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1081914, encodeId=28ec10819141d, content=国内什么时候上市, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecc72219008, createdName=13320f3bd5m, createdTime=Sun Dec 19 22:09:39 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643060, encodeId=3f99164306010, content=<a href='/topic/show?id=0c3d5e2871' target=_blank style='color:#2F92EE;'>#Dayvigo#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5728, encryptionId=0c3d5e2871, topicName=Dayvigo)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1e223091112, createdName=bshuang, createdTime=Sat Aug 01 20:43:00 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725183, encodeId=cb2e1e251836a, content=<a href='/topic/show?id=58476021257' target=_blank style='color:#2F92EE;'>#曙光#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60212, encryptionId=58476021257, topicName=曙光)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=180c33737541, createdName=yangpeizhi, createdTime=Mon Jun 01 12:43:00 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377482, encodeId=22893e7482b2, content=好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/12/3ce6763501d2a73b61c6ba263da91b0a.jpg, createdBy=b41a2669073, createdName=280218318, createdTime=Fri Dec 27 10:41:55 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377455, encodeId=00a13e7455ee, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201031/68bd1e468a5b4b94a6d4d57ed4253bc5/e6bf210dcac542b890ccc1ae1e433a21.jpg, createdBy=2eb51948381, createdName=1e109f88m97(暂无匿称), createdTime=Thu Dec 26 17:11:13 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377436, encodeId=f86e3e7436b5, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/03/0e492dda8bcc1f98474b74c2863aca87.jpg, createdBy=068d2446376, createdName=Dr Z, createdTime=Thu Dec 26 06:22:57 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1299388, encodeId=9c481299388ce, content=<a href='/topic/show?id=59d64429252' target=_blank style='color:#2F92EE;'>#失眠症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44292, encryptionId=59d64429252, topicName=失眠症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a4d285, createdName=日月, createdTime=Thu Dec 26 00:43:00 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447948, encodeId=975a144e9482c, content=<a href='/topic/show?id=72233658193' target=_blank style='color:#2F92EE;'>#卫材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36581, encryptionId=72233658193, topicName=卫材)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de215370353, createdName=yyanpro@23cn.c, createdTime=Thu Dec 26 00:43:00 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377408, encodeId=66993e740891, content=好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xjZ9qh3bhXrJtUlmycKGfQKPuADVZQsdNAQj5IrHHlzbGsDwScictBgogYRk8KhicpgEKwTEfOHgqw/0, createdBy=bc931611963, createdName=jin321, createdTime=Wed Dec 25 12:49:50 CST 2019, time=2019-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377390, encodeId=be0d3e739092, content=好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Wed Dec 25 05:14:27 CST 2019, time=2019-12-25, status=1, ipAttribution=)]
    2020-08-01 bshuang

    #Dayvigo#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1081914, encodeId=28ec10819141d, content=国内什么时候上市, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecc72219008, createdName=13320f3bd5m, createdTime=Sun Dec 19 22:09:39 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643060, encodeId=3f99164306010, content=<a href='/topic/show?id=0c3d5e2871' target=_blank style='color:#2F92EE;'>#Dayvigo#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5728, encryptionId=0c3d5e2871, topicName=Dayvigo)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1e223091112, createdName=bshuang, createdTime=Sat Aug 01 20:43:00 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725183, encodeId=cb2e1e251836a, content=<a href='/topic/show?id=58476021257' target=_blank style='color:#2F92EE;'>#曙光#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60212, encryptionId=58476021257, topicName=曙光)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=180c33737541, createdName=yangpeizhi, createdTime=Mon Jun 01 12:43:00 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377482, encodeId=22893e7482b2, content=好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/12/3ce6763501d2a73b61c6ba263da91b0a.jpg, createdBy=b41a2669073, createdName=280218318, createdTime=Fri Dec 27 10:41:55 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377455, encodeId=00a13e7455ee, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201031/68bd1e468a5b4b94a6d4d57ed4253bc5/e6bf210dcac542b890ccc1ae1e433a21.jpg, createdBy=2eb51948381, createdName=1e109f88m97(暂无匿称), createdTime=Thu Dec 26 17:11:13 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377436, encodeId=f86e3e7436b5, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/03/0e492dda8bcc1f98474b74c2863aca87.jpg, createdBy=068d2446376, createdName=Dr Z, createdTime=Thu Dec 26 06:22:57 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1299388, encodeId=9c481299388ce, content=<a href='/topic/show?id=59d64429252' target=_blank style='color:#2F92EE;'>#失眠症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44292, encryptionId=59d64429252, topicName=失眠症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a4d285, createdName=日月, createdTime=Thu Dec 26 00:43:00 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447948, encodeId=975a144e9482c, content=<a href='/topic/show?id=72233658193' target=_blank style='color:#2F92EE;'>#卫材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36581, encryptionId=72233658193, topicName=卫材)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de215370353, createdName=yyanpro@23cn.c, createdTime=Thu Dec 26 00:43:00 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377408, encodeId=66993e740891, content=好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xjZ9qh3bhXrJtUlmycKGfQKPuADVZQsdNAQj5IrHHlzbGsDwScictBgogYRk8KhicpgEKwTEfOHgqw/0, createdBy=bc931611963, createdName=jin321, createdTime=Wed Dec 25 12:49:50 CST 2019, time=2019-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377390, encodeId=be0d3e739092, content=好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Wed Dec 25 05:14:27 CST 2019, time=2019-12-25, status=1, ipAttribution=)]
    2020-06-01 yangpeizhi

    #曙光#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1081914, encodeId=28ec10819141d, content=国内什么时候上市, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecc72219008, createdName=13320f3bd5m, createdTime=Sun Dec 19 22:09:39 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643060, encodeId=3f99164306010, content=<a href='/topic/show?id=0c3d5e2871' target=_blank style='color:#2F92EE;'>#Dayvigo#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5728, encryptionId=0c3d5e2871, topicName=Dayvigo)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1e223091112, createdName=bshuang, createdTime=Sat Aug 01 20:43:00 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725183, encodeId=cb2e1e251836a, content=<a href='/topic/show?id=58476021257' target=_blank style='color:#2F92EE;'>#曙光#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60212, encryptionId=58476021257, topicName=曙光)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=180c33737541, createdName=yangpeizhi, createdTime=Mon Jun 01 12:43:00 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377482, encodeId=22893e7482b2, content=好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/12/3ce6763501d2a73b61c6ba263da91b0a.jpg, createdBy=b41a2669073, createdName=280218318, createdTime=Fri Dec 27 10:41:55 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377455, encodeId=00a13e7455ee, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201031/68bd1e468a5b4b94a6d4d57ed4253bc5/e6bf210dcac542b890ccc1ae1e433a21.jpg, createdBy=2eb51948381, createdName=1e109f88m97(暂无匿称), createdTime=Thu Dec 26 17:11:13 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377436, encodeId=f86e3e7436b5, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/03/0e492dda8bcc1f98474b74c2863aca87.jpg, createdBy=068d2446376, createdName=Dr Z, createdTime=Thu Dec 26 06:22:57 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1299388, encodeId=9c481299388ce, content=<a href='/topic/show?id=59d64429252' target=_blank style='color:#2F92EE;'>#失眠症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44292, encryptionId=59d64429252, topicName=失眠症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a4d285, createdName=日月, createdTime=Thu Dec 26 00:43:00 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447948, encodeId=975a144e9482c, content=<a href='/topic/show?id=72233658193' target=_blank style='color:#2F92EE;'>#卫材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36581, encryptionId=72233658193, topicName=卫材)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de215370353, createdName=yyanpro@23cn.c, createdTime=Thu Dec 26 00:43:00 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377408, encodeId=66993e740891, content=好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xjZ9qh3bhXrJtUlmycKGfQKPuADVZQsdNAQj5IrHHlzbGsDwScictBgogYRk8KhicpgEKwTEfOHgqw/0, createdBy=bc931611963, createdName=jin321, createdTime=Wed Dec 25 12:49:50 CST 2019, time=2019-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377390, encodeId=be0d3e739092, content=好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Wed Dec 25 05:14:27 CST 2019, time=2019-12-25, status=1, ipAttribution=)]
    2019-12-27 280218318

    好东西

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1081914, encodeId=28ec10819141d, content=国内什么时候上市, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecc72219008, createdName=13320f3bd5m, createdTime=Sun Dec 19 22:09:39 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643060, encodeId=3f99164306010, content=<a href='/topic/show?id=0c3d5e2871' target=_blank style='color:#2F92EE;'>#Dayvigo#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5728, encryptionId=0c3d5e2871, topicName=Dayvigo)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1e223091112, createdName=bshuang, createdTime=Sat Aug 01 20:43:00 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725183, encodeId=cb2e1e251836a, content=<a href='/topic/show?id=58476021257' target=_blank style='color:#2F92EE;'>#曙光#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60212, encryptionId=58476021257, topicName=曙光)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=180c33737541, createdName=yangpeizhi, createdTime=Mon Jun 01 12:43:00 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377482, encodeId=22893e7482b2, content=好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/12/3ce6763501d2a73b61c6ba263da91b0a.jpg, createdBy=b41a2669073, createdName=280218318, createdTime=Fri Dec 27 10:41:55 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377455, encodeId=00a13e7455ee, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201031/68bd1e468a5b4b94a6d4d57ed4253bc5/e6bf210dcac542b890ccc1ae1e433a21.jpg, createdBy=2eb51948381, createdName=1e109f88m97(暂无匿称), createdTime=Thu Dec 26 17:11:13 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377436, encodeId=f86e3e7436b5, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/03/0e492dda8bcc1f98474b74c2863aca87.jpg, createdBy=068d2446376, createdName=Dr Z, createdTime=Thu Dec 26 06:22:57 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1299388, encodeId=9c481299388ce, content=<a href='/topic/show?id=59d64429252' target=_blank style='color:#2F92EE;'>#失眠症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44292, encryptionId=59d64429252, topicName=失眠症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a4d285, createdName=日月, createdTime=Thu Dec 26 00:43:00 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447948, encodeId=975a144e9482c, content=<a href='/topic/show?id=72233658193' target=_blank style='color:#2F92EE;'>#卫材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36581, encryptionId=72233658193, topicName=卫材)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de215370353, createdName=yyanpro@23cn.c, createdTime=Thu Dec 26 00:43:00 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377408, encodeId=66993e740891, content=好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xjZ9qh3bhXrJtUlmycKGfQKPuADVZQsdNAQj5IrHHlzbGsDwScictBgogYRk8KhicpgEKwTEfOHgqw/0, createdBy=bc931611963, createdName=jin321, createdTime=Wed Dec 25 12:49:50 CST 2019, time=2019-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377390, encodeId=be0d3e739092, content=好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Wed Dec 25 05:14:27 CST 2019, time=2019-12-25, status=1, ipAttribution=)]
    2019-12-26 1e109f88m97(暂无匿称)

    学习

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1081914, encodeId=28ec10819141d, content=国内什么时候上市, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecc72219008, createdName=13320f3bd5m, createdTime=Sun Dec 19 22:09:39 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643060, encodeId=3f99164306010, content=<a href='/topic/show?id=0c3d5e2871' target=_blank style='color:#2F92EE;'>#Dayvigo#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5728, encryptionId=0c3d5e2871, topicName=Dayvigo)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1e223091112, createdName=bshuang, createdTime=Sat Aug 01 20:43:00 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725183, encodeId=cb2e1e251836a, content=<a href='/topic/show?id=58476021257' target=_blank style='color:#2F92EE;'>#曙光#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60212, encryptionId=58476021257, topicName=曙光)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=180c33737541, createdName=yangpeizhi, createdTime=Mon Jun 01 12:43:00 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377482, encodeId=22893e7482b2, content=好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/12/3ce6763501d2a73b61c6ba263da91b0a.jpg, createdBy=b41a2669073, createdName=280218318, createdTime=Fri Dec 27 10:41:55 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377455, encodeId=00a13e7455ee, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201031/68bd1e468a5b4b94a6d4d57ed4253bc5/e6bf210dcac542b890ccc1ae1e433a21.jpg, createdBy=2eb51948381, createdName=1e109f88m97(暂无匿称), createdTime=Thu Dec 26 17:11:13 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377436, encodeId=f86e3e7436b5, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/03/0e492dda8bcc1f98474b74c2863aca87.jpg, createdBy=068d2446376, createdName=Dr Z, createdTime=Thu Dec 26 06:22:57 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1299388, encodeId=9c481299388ce, content=<a href='/topic/show?id=59d64429252' target=_blank style='color:#2F92EE;'>#失眠症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44292, encryptionId=59d64429252, topicName=失眠症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a4d285, createdName=日月, createdTime=Thu Dec 26 00:43:00 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447948, encodeId=975a144e9482c, content=<a href='/topic/show?id=72233658193' target=_blank style='color:#2F92EE;'>#卫材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36581, encryptionId=72233658193, topicName=卫材)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de215370353, createdName=yyanpro@23cn.c, createdTime=Thu Dec 26 00:43:00 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377408, encodeId=66993e740891, content=好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xjZ9qh3bhXrJtUlmycKGfQKPuADVZQsdNAQj5IrHHlzbGsDwScictBgogYRk8KhicpgEKwTEfOHgqw/0, createdBy=bc931611963, createdName=jin321, createdTime=Wed Dec 25 12:49:50 CST 2019, time=2019-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377390, encodeId=be0d3e739092, content=好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Wed Dec 25 05:14:27 CST 2019, time=2019-12-25, status=1, ipAttribution=)]
    2019-12-26 Dr Z

    学习了

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1081914, encodeId=28ec10819141d, content=国内什么时候上市, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecc72219008, createdName=13320f3bd5m, createdTime=Sun Dec 19 22:09:39 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643060, encodeId=3f99164306010, content=<a href='/topic/show?id=0c3d5e2871' target=_blank style='color:#2F92EE;'>#Dayvigo#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5728, encryptionId=0c3d5e2871, topicName=Dayvigo)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1e223091112, createdName=bshuang, createdTime=Sat Aug 01 20:43:00 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725183, encodeId=cb2e1e251836a, content=<a href='/topic/show?id=58476021257' target=_blank style='color:#2F92EE;'>#曙光#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60212, encryptionId=58476021257, topicName=曙光)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=180c33737541, createdName=yangpeizhi, createdTime=Mon Jun 01 12:43:00 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377482, encodeId=22893e7482b2, content=好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/12/3ce6763501d2a73b61c6ba263da91b0a.jpg, createdBy=b41a2669073, createdName=280218318, createdTime=Fri Dec 27 10:41:55 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377455, encodeId=00a13e7455ee, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201031/68bd1e468a5b4b94a6d4d57ed4253bc5/e6bf210dcac542b890ccc1ae1e433a21.jpg, createdBy=2eb51948381, createdName=1e109f88m97(暂无匿称), createdTime=Thu Dec 26 17:11:13 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377436, encodeId=f86e3e7436b5, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/03/0e492dda8bcc1f98474b74c2863aca87.jpg, createdBy=068d2446376, createdName=Dr Z, createdTime=Thu Dec 26 06:22:57 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1299388, encodeId=9c481299388ce, content=<a href='/topic/show?id=59d64429252' target=_blank style='color:#2F92EE;'>#失眠症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44292, encryptionId=59d64429252, topicName=失眠症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a4d285, createdName=日月, createdTime=Thu Dec 26 00:43:00 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447948, encodeId=975a144e9482c, content=<a href='/topic/show?id=72233658193' target=_blank style='color:#2F92EE;'>#卫材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36581, encryptionId=72233658193, topicName=卫材)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de215370353, createdName=yyanpro@23cn.c, createdTime=Thu Dec 26 00:43:00 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377408, encodeId=66993e740891, content=好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xjZ9qh3bhXrJtUlmycKGfQKPuADVZQsdNAQj5IrHHlzbGsDwScictBgogYRk8KhicpgEKwTEfOHgqw/0, createdBy=bc931611963, createdName=jin321, createdTime=Wed Dec 25 12:49:50 CST 2019, time=2019-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377390, encodeId=be0d3e739092, content=好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Wed Dec 25 05:14:27 CST 2019, time=2019-12-25, status=1, ipAttribution=)]
    2019-12-26 日月

    #失眠症#

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1081914, encodeId=28ec10819141d, content=国内什么时候上市, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecc72219008, createdName=13320f3bd5m, createdTime=Sun Dec 19 22:09:39 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643060, encodeId=3f99164306010, content=<a href='/topic/show?id=0c3d5e2871' target=_blank style='color:#2F92EE;'>#Dayvigo#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5728, encryptionId=0c3d5e2871, topicName=Dayvigo)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1e223091112, createdName=bshuang, createdTime=Sat Aug 01 20:43:00 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725183, encodeId=cb2e1e251836a, content=<a href='/topic/show?id=58476021257' target=_blank style='color:#2F92EE;'>#曙光#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60212, encryptionId=58476021257, topicName=曙光)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=180c33737541, createdName=yangpeizhi, createdTime=Mon Jun 01 12:43:00 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377482, encodeId=22893e7482b2, content=好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/12/3ce6763501d2a73b61c6ba263da91b0a.jpg, createdBy=b41a2669073, createdName=280218318, createdTime=Fri Dec 27 10:41:55 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377455, encodeId=00a13e7455ee, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201031/68bd1e468a5b4b94a6d4d57ed4253bc5/e6bf210dcac542b890ccc1ae1e433a21.jpg, createdBy=2eb51948381, createdName=1e109f88m97(暂无匿称), createdTime=Thu Dec 26 17:11:13 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377436, encodeId=f86e3e7436b5, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/03/0e492dda8bcc1f98474b74c2863aca87.jpg, createdBy=068d2446376, createdName=Dr Z, createdTime=Thu Dec 26 06:22:57 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1299388, encodeId=9c481299388ce, content=<a href='/topic/show?id=59d64429252' target=_blank style='color:#2F92EE;'>#失眠症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44292, encryptionId=59d64429252, topicName=失眠症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a4d285, createdName=日月, createdTime=Thu Dec 26 00:43:00 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447948, encodeId=975a144e9482c, content=<a href='/topic/show?id=72233658193' target=_blank style='color:#2F92EE;'>#卫材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36581, encryptionId=72233658193, topicName=卫材)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de215370353, createdName=yyanpro@23cn.c, createdTime=Thu Dec 26 00:43:00 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377408, encodeId=66993e740891, content=好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xjZ9qh3bhXrJtUlmycKGfQKPuADVZQsdNAQj5IrHHlzbGsDwScictBgogYRk8KhicpgEKwTEfOHgqw/0, createdBy=bc931611963, createdName=jin321, createdTime=Wed Dec 25 12:49:50 CST 2019, time=2019-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377390, encodeId=be0d3e739092, content=好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Wed Dec 25 05:14:27 CST 2019, time=2019-12-25, status=1, ipAttribution=)]
    2019-12-26 yyanpro@23cn.c

    #卫材#

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1081914, encodeId=28ec10819141d, content=国内什么时候上市, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecc72219008, createdName=13320f3bd5m, createdTime=Sun Dec 19 22:09:39 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643060, encodeId=3f99164306010, content=<a href='/topic/show?id=0c3d5e2871' target=_blank style='color:#2F92EE;'>#Dayvigo#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5728, encryptionId=0c3d5e2871, topicName=Dayvigo)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1e223091112, createdName=bshuang, createdTime=Sat Aug 01 20:43:00 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725183, encodeId=cb2e1e251836a, content=<a href='/topic/show?id=58476021257' target=_blank style='color:#2F92EE;'>#曙光#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60212, encryptionId=58476021257, topicName=曙光)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=180c33737541, createdName=yangpeizhi, createdTime=Mon Jun 01 12:43:00 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377482, encodeId=22893e7482b2, content=好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/12/3ce6763501d2a73b61c6ba263da91b0a.jpg, createdBy=b41a2669073, createdName=280218318, createdTime=Fri Dec 27 10:41:55 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377455, encodeId=00a13e7455ee, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201031/68bd1e468a5b4b94a6d4d57ed4253bc5/e6bf210dcac542b890ccc1ae1e433a21.jpg, createdBy=2eb51948381, createdName=1e109f88m97(暂无匿称), createdTime=Thu Dec 26 17:11:13 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377436, encodeId=f86e3e7436b5, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/03/0e492dda8bcc1f98474b74c2863aca87.jpg, createdBy=068d2446376, createdName=Dr Z, createdTime=Thu Dec 26 06:22:57 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1299388, encodeId=9c481299388ce, content=<a href='/topic/show?id=59d64429252' target=_blank style='color:#2F92EE;'>#失眠症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44292, encryptionId=59d64429252, topicName=失眠症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a4d285, createdName=日月, createdTime=Thu Dec 26 00:43:00 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447948, encodeId=975a144e9482c, content=<a href='/topic/show?id=72233658193' target=_blank style='color:#2F92EE;'>#卫材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36581, encryptionId=72233658193, topicName=卫材)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de215370353, createdName=yyanpro@23cn.c, createdTime=Thu Dec 26 00:43:00 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377408, encodeId=66993e740891, content=好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xjZ9qh3bhXrJtUlmycKGfQKPuADVZQsdNAQj5IrHHlzbGsDwScictBgogYRk8KhicpgEKwTEfOHgqw/0, createdBy=bc931611963, createdName=jin321, createdTime=Wed Dec 25 12:49:50 CST 2019, time=2019-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377390, encodeId=be0d3e739092, content=好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Wed Dec 25 05:14:27 CST 2019, time=2019-12-25, status=1, ipAttribution=)]
    2019-12-25 jin321

    好东西

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1081914, encodeId=28ec10819141d, content=国内什么时候上市, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecc72219008, createdName=13320f3bd5m, createdTime=Sun Dec 19 22:09:39 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643060, encodeId=3f99164306010, content=<a href='/topic/show?id=0c3d5e2871' target=_blank style='color:#2F92EE;'>#Dayvigo#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5728, encryptionId=0c3d5e2871, topicName=Dayvigo)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1e223091112, createdName=bshuang, createdTime=Sat Aug 01 20:43:00 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725183, encodeId=cb2e1e251836a, content=<a href='/topic/show?id=58476021257' target=_blank style='color:#2F92EE;'>#曙光#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60212, encryptionId=58476021257, topicName=曙光)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=180c33737541, createdName=yangpeizhi, createdTime=Mon Jun 01 12:43:00 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377482, encodeId=22893e7482b2, content=好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/12/3ce6763501d2a73b61c6ba263da91b0a.jpg, createdBy=b41a2669073, createdName=280218318, createdTime=Fri Dec 27 10:41:55 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377455, encodeId=00a13e7455ee, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201031/68bd1e468a5b4b94a6d4d57ed4253bc5/e6bf210dcac542b890ccc1ae1e433a21.jpg, createdBy=2eb51948381, createdName=1e109f88m97(暂无匿称), createdTime=Thu Dec 26 17:11:13 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377436, encodeId=f86e3e7436b5, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/03/0e492dda8bcc1f98474b74c2863aca87.jpg, createdBy=068d2446376, createdName=Dr Z, createdTime=Thu Dec 26 06:22:57 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1299388, encodeId=9c481299388ce, content=<a href='/topic/show?id=59d64429252' target=_blank style='color:#2F92EE;'>#失眠症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44292, encryptionId=59d64429252, topicName=失眠症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a4d285, createdName=日月, createdTime=Thu Dec 26 00:43:00 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447948, encodeId=975a144e9482c, content=<a href='/topic/show?id=72233658193' target=_blank style='color:#2F92EE;'>#卫材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36581, encryptionId=72233658193, topicName=卫材)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de215370353, createdName=yyanpro@23cn.c, createdTime=Thu Dec 26 00:43:00 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377408, encodeId=66993e740891, content=好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xjZ9qh3bhXrJtUlmycKGfQKPuADVZQsdNAQj5IrHHlzbGsDwScictBgogYRk8KhicpgEKwTEfOHgqw/0, createdBy=bc931611963, createdName=jin321, createdTime=Wed Dec 25 12:49:50 CST 2019, time=2019-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377390, encodeId=be0d3e739092, content=好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Wed Dec 25 05:14:27 CST 2019, time=2019-12-25, status=1, ipAttribution=)]
    2019-12-25 yjs木玉

    好好好好好好

    0

以上为热门评论，梅斯医学App还有更多内容

相关资讯

Zotiraciclib治疗胶质母细胞瘤被FDA和EMA授予孤儿药称号

Zotiraciclib用于治疗胶质母细胞瘤，已被美国食品和药物管理局（FDA）和欧洲药品管理局（EMA）授予孤儿药指定（ODD）。该药物的指定是基于两项Ib期胶质母细胞瘤的临床研究。

美国批准默克的埃博拉病毒预防疫苗上市

美国监管机构已经批准了默克的Ervebo（rVSVΔG-ZEBOV-GP），这是首款在美国获得市场批准的埃博拉病毒（EVD）预防疫苗。

lebrikizumab获得FDA快速通道资格用以治疗特应性皮炎

Dermira制药公司近日宣布，FDA已经授予lebrikizumab快速通道资格，用于治疗中度至重度特应性皮炎患者。Dermira首席执行官Tom Wiggans表示：“如果在进行中的III期研究中证实了II期研究的结果，那么这种快速通道资格将加快lebrikizumab的上市”。

Xtandi成**获批FDA 前列腺癌口服疗法

今日，安斯泰来（Astellas）和辉瑞（Pfizer）公司宣布，美国FDA批准Xtandi（enzalutamide）扩展适应症，治疗转移性激素敏感性前列腺癌（mHSPC）患者。新闻稿指出，这一批准，让Xtandi成为首款获得FDA批准，治疗三种不同形态晚期前列腺癌（非转移性和转移性去势抵抗性前列腺癌，和转移性去势敏感性前列腺癌）的口服疗法。

FDA专家组投票赞成，批准Keytruda治疗难治性膀胱癌

在FDA专家小组的投票之后，默克（Merck）的检查点抑制剂PD-1单抗Keytruda在美国获批了新的适应症--早期膀胱癌的治疗。

百时美施贵宝宣布向FDA申请其CAR-T细胞疗法liso-cel的许可

百时美施贵宝公司今天宣布向美国食品药品监督管理局（FDA）提交其CAR-T细胞疗法lisocabtagene maraleucel（liso-cel）的生物许可证申请（BLA）。

Baidu
map
Baidu
map
Baidu
map